Osaic Holdings’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-889
| Closed | – | – | 7903 |
|
|
2025
Q2 | $0 | Hold |
889
| – | – | ﹤0.01% | 7747 |
|
|
2025
Q1 | $622 | Buy |
+889
| New | +$1.01K | ﹤0.01% | 6948 |
|
|
2024
Q4 | – | Sell |
-3
| Closed | -$5 | – | 7408 |
|
|
2024
Q3 | $5 | Hold |
3
| – | – | ﹤0.01% | 7363 |
|
|
2024
Q2 | $3 | Hold |
3
| – | – | ﹤0.01% | 7370 |
|
|
2024
Q1 | $2 | Buy |
+3
| New | +$5 | ﹤0.01% | 7175 |
|
|
2023
Q3 | – | Sell |
-173
| Closed | -$1.41K | – | 7396 |
|
|
2023
Q2 | $1.41K | Hold |
173
| – | – | ﹤0.01% | 6778 |
|
|
2023
Q1 | $1.21K | Hold |
173
| – | – | ﹤0.01% | 6889 |
|
|
2022
Q4 | $1K | Hold |
173
| – | – | ﹤0.01% | 6827 |
|
|
2022
Q3 | $3K | Hold |
173
| – | – | ﹤0.01% | 6579 |
|
|
2022
Q2 | $2K | Sell |
173
-227
| -57% | -$2.01K | ﹤0.01% | 6841 |
|
|
2022
Q1 | $6K | Buy |
400
+227
| +131% | +$6.46K | ﹤0.01% | 6377 |
|
|
2021
Q4 | $9K | Buy |
+173
| New | +$9.63K | ﹤0.01% | 6313 |
|
|
2021
Q1 | – | Sell |
-900
| Closed | -$68K | – | 6792 |
|
|
2020
Q4 | $68K | Sell |
900
-50
| -5% | -$4.48K | ﹤0.01% | 4331 |
|
|
2020
Q3 | $101K | Sell |
950
-10
| -1% | -$1.39K | ﹤0.01% | 3826 |
|
|
2020
Q2 | $145K | Buy |
960
+50
| +5% | +$4.93K | ﹤0.01% | 3396 |
|
|
2020
Q1 | $76K | Buy |
+910
| New | +$128K | ﹤0.01% | 3677 |
|
Osaic Holdings's AXDX Position: Q3 2025 in Review
Osaic Holdings sold out of Accelerate Diagnostics (AXDX) in Q3 2025, closing a stake of 889 shares.
Osaic Holdings first reported a position in AXDX in Q1 2020 and held it in 16 quarters. The position peaked at $145K in Q2 2020. 0 funds tracked by Wall St. Rank hold AXDX as of Q3 2025.
- Osaic Holdings reported no remaining Accelerate Diagnostics position as of Q3 2025 after selling out during the quarter.
- Osaic Holdings sold 889 Accelerate Diagnostics shares in Q3 2025.
- Osaic Holdings first reported a position in Accelerate Diagnostics in Q1 2020 and held it in 16 quarters.
- Osaic Holdings's Accelerate Diagnostics position peaked at $145K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2025.
Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.